These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20065930)

  • 1. Dysglycemia/prediabetes and cardiovascular risk factors.
    Hanna-Moussa A; Gardner MJ; Kurukulasuriya LR; Sowers JR
    Rev Cardiovasc Med; 2009; 10(4):202-8. PubMed ID: 20065930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
    Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
    Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Prediabetes in the Metabolic Syndrome: Guilt by Association.
    Davidson MB
    Metab Syndr Relat Disord; 2023 May; 21(4):197-204. PubMed ID: 37042661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of prediabetes.
    Abdul-Ghani MA; DeFronzo RA
    Curr Diab Rep; 2009 Jun; 9(3):193-9. PubMed ID: 19490820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is metabolic syndrome a condition independent of prediabetes and type 2 diabetes mellitus? A report from Turkey.
    Uzunlulu M; Oguz A
    Endocr J; 2007 Dec; 54(5):745-50. PubMed ID: 17878610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediabetes: Why Should We Care?
    Zand A; Ibrahim K; Patham B
    Methodist Debakey Cardiovasc J; 2018; 14(4):289-297. PubMed ID: 30788015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic implications of diabetes in cardiovascular disease.
    Cherian B; Meka N; Katragadda S; Arora R
    Am J Ther; 2009; 16(6):e51-9. PubMed ID: 19940606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prediabetes: diagnosis, evaluation of chronic complications, and treatment].
    Souza CF; Gross JL; Gerchman F; Leitão CB
    Arq Bras Endocrinol Metabol; 2012 Jul; 56(5):275-84. PubMed ID: 22911279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection and integrated management of dysglycemia in cardiovascular disease: a key factor for decreasing the likelihood of future events.
    Anselmino M; Mellbin L; Wallander M; Rydén L
    Rev Cardiovasc Med; 2008; 9(1):29-38. PubMed ID: 18418307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of a bi-directional relationship between heart failure and diabetes: a strategy for the detection of glucose abnormalities and diabetes prevention in patients with heart failure.
    Valensi P
    Cardiovasc Diabetol; 2024 Sep; 23(1):354. PubMed ID: 39342254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk stratification and management in pre-diabetes.
    Færch K; Vistisen D; Johansen NB; Jørgensen ME
    Curr Diab Rep; 2014 Jun; 14(6):493. PubMed ID: 24743942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose.
    DeFronzo RA; Abdul-Ghani M
    Am J Cardiol; 2011 Aug; 108(3 Suppl):3B-24B. PubMed ID: 21802577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
    Krum H; McMurray JJ; Horton E; Gerlock T; Holzhauer B; Zuurman L; Haffner SM; Bethel MA; Holman RR; Califf RM
    Cardiovasc Ther; 2010 Apr; 28(2):124-32. PubMed ID: 20184589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study.
    Perreault L; Temprosa M; Mather KJ; Horton E; Kitabchi A; Larkin M; Montez MG; Thayer D; Orchard TJ; Hamman RF; Goldberg RB;
    Diabetes Care; 2014 Sep; 37(9):2622-31. PubMed ID: 24969574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.
    Brannick B; Dagogo-Jack S
    Endocrinol Metab Clin North Am; 2018 Mar; 47(1):33-50. PubMed ID: 29407055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients.
    Charfen MA; Ipp E; Kaji AH; Saleh T; Qazi MF; Lewis RJ
    Acad Emerg Med; 2009 May; 16(5):394-402. PubMed ID: 19302369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes.
    Luo Y; Paul SK; Zhou X; Chang C; Chen W; Guo X; Yang J; Ji L; Wang H
    J Diabetes Res; 2017; 2017():7602408. PubMed ID: 28168204
    [No Abstract]   [Full Text] [Related]  

  • 19. Prediabetes: a position statement from the Australian Diabetes Society and Australian Diabetes Educators Association.
    Twigg SM; Kamp MC; Davis TM; Neylon EK; Flack JR; ;
    Med J Aust; 2007 May; 186(9):461-5. PubMed ID: 17484708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of vascular complications in prediabetes.
    Milman S; Crandall JP
    Med Clin North Am; 2011 Mar; 95(2):309-25, vii. PubMed ID: 21281835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.